28 January 2022 · Commissioning policies for the use of oral antivirals or nMABs in the treatment of both hospital-onset and non-hospitalised patients with COVID-19.
17 September 2021 · The NHSEI policy covers the criteria through which these medicines are recommended to be made available for adults and children (aged 12 years and above).
10 August 2021 · DHSC and NHSEI advise inhaled budesonide should no longer be used to treat individuals with COVID-19 infection other than within the context of a clinical trial
23 July 2021 · Guidance includes advice for patients with kidney transplants and those who are immunosuppressed. Medicines related advice is summarised.
26 May 2021 · Allergy UK has created frequently asked questions on coronavirus aimed at people living with allergy. Medicines related advice is summarised.
9 April 2021 · During certain periods, it may be more necessary than normal to give some medicines by bolus injection for neonates, children and young people
18 February 2021 · During COVID-19, oxygen in care homes for those with underlying lung conditions may be more needed than normal. Its use needs to be managed by appropriate teams
9 February 2021 · Consider three steps when planning access to end of life care medicines in out-of-hospital settings during a pandemic. Four practice points are also shared.
9 February 2021 · Organisations have shared examples with SPS of how to meet this challenge. These can be used and adapted locally dependent on organisational fit.